Men with prostate cancer who were not eligible for germline (hereditary) genetic testing were just as likely to carry pathogenic variants that could be treated as men who were eligible for this testing, according to a new study funded by a genetics testing company. And men who identified as non-White (mainly Black) men who did …
Residents of 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 64 percent less likely than residents living in A (“Best”) areas to meet colorectal cancer screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a long …
Women living in 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 79 percent less likely than women living in A (“Best”) areas to meet cervical cancer screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a …
Men diagnosed with early-onset prostate cancer (at age 55 or younger) are more likely to die sooner if they’re Black, don’t have health insurance, and live in lower-income areas with high levels of people who didn’t finish high school. That’s the finding fromn the first study to investigate how socioeconomic status (SES) affects survival in …
Socioeconomic disadvantages can shorten lifespan of men with early-onset prostate cancer Read More »
Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed …
Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed …
Black patients with advanced colorectal cancer had a 12.6% reduction in mortality in Medicaid-expansion states, compared with a 6.1% reduction in nonexpanded states. Naveen Manisundaram, MD (above), and his colleagues at The University of Texas MD Anderson Cancer Center in Houston analyzed data from the National Cancer Database to compare mortality rates for patients with …
Mailing human papillomavirus (HPV) self-collection tests and offering assistance to book screening appointments to under-screened, low-income women improved cervical cancer screening nearly two-fold compared to scheduling assistance alone. “Many hadn’t engaged in the screening system for a while and getting the kit to their homes helped break down a fundamental barrier,” said researcher Jennifer Smith, …
Cervical cancer screening doubles when unscreened women are mailed testing kits Read More »
Four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer have been identified from health insurance data on more than 5,000 patients with early-onset colorectal cancer. This is cancer that occurs before a person turns 50. The number of young adults with colorectal cancer has nearly doubled in recent years. Researchers …
Colorectal cancer patients of African ancestry are less likely to have tumors that respond well to two important classes of newer treatments: immunotherapy and targeted therapy, according to an analysis of genetic data from 4,441 people treated for colorectal cancer at Memorial Sloan Kettering Cancer Center in New York. These treatments work better against tumors …
Information provided on this website is neither intended nor implied to be a substitute for professional medical advice and is not intended to replace the services of a physician.
You should not use information on this web site or the information on links from this site to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
